Long-term Effect of Plasma-derived Vaccine in the Prevention of Hepatitis B (eighteen Years'Follow-up Study)

吴维寿,孙超美,姜铭波,张国华,周宁,欧阳佩英,汪萱怡,徐志一
DOI: https://doi.org/10.3969/j.issn.1006-916x.2005.03.010
2005-01-01
Abstract:Objective To evaluate the long-term effectiveness of the universal infant HBV immunization in Shanghai. Method The 1986 birth cohort who received HBV vaccine was followed every 1-2 years during 1986-2004. Blood specimens were collected and tested for HBsAg, anti-HBS, and anti-HBC. Results The HBV vaccine coverage rate was around or over 95%.In the 11 follow-ups studies in 18 years, 5332 blood specimens were collected and tested.The HBsAg sero-positivity rate is 1%. The average positivity of HBsAg is 0.62%, if shows that HBsAg positivity rate decreased. Compared to the HBsAg positivity rate before the immunization program,the long-term effectiveness was thus estimated at 93.64%(95%CI:92.51%-94.78%).The rate of the vaccinated subjects with anti-HBs of≥10mIU/mL, declined form 89% in 1987 to 30.1% in 2004. Conclusion This decline, however,had no impact on the HBsAg carrier rate in the immunized cohort and thus is not an indicator for revaccination.
What problem does this paper attempt to address?